Fucoidans and Bowel Health

Mar Drugs. 2021 Jul 30;19(8):436. doi: 10.3390/md19080436.

Abstract

Fucoidans are cell wall polysaccharides found in various species of brown seaweeds. They are fucose-containing sulfated polysaccharides (FCSPs) and comprise 5-20% of the algal dry weight. Fucoidans possess multiple bioactivities, including antioxidant, anticoagulant, antithrombotic, anti-inflammatory, antiviral, anti-lipidemic, anti-metastatic, anti-diabetic and anti-cancer effects. Dietary fucoidans provide small but constant amounts of FCSPs to the intestinal tract, which can reorganize the composition of commensal microbiota altered by FCSPs, and consequently control inflammation symptoms in the intestine. Although the bioactivities of fucoidans have been well described, there is limited evidence to implicate their effect on gut microbiota and bowel health. In this review, we summarize the recent studies that introduce the fundamental characteristics of various kinds of fucoidans and discuss their potential in altering commensal microorganisms and influencing intestinal diseases.

Keywords: fucoidan; gut microbiota; immunity; inflammation; intestinal function.

Publication types

  • Review

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use*
  • Aquatic Organisms
  • Colitis / prevention & control*
  • Humans
  • Phytotherapy
  • Polysaccharides / therapeutic use*
  • Seaweed*

Substances

  • Anti-Inflammatory Agents
  • Polysaccharides
  • fucoidan